BRCA1 and breast carcinoma: Indeed, only Ursin et al., and Marchbanks et al., mentioned in their discussion sections the possible influence of BRCA1 and BRCA2 mutations on the occurrence of breast cancer with the simultaneous use of OC [65,94].